BR0303012A - Avaliação de câncer colorretal - Google Patents
Avaliação de câncer colorretalInfo
- Publication number
- BR0303012A BR0303012A BR0303012-1A BR0303012A BR0303012A BR 0303012 A BR0303012 A BR 0303012A BR 0303012 A BR0303012 A BR 0303012A BR 0303012 A BR0303012 A BR 0303012A
- Authority
- BR
- Brazil
- Prior art keywords
- colorectal cancer
- cancer assessment
- cancer
- assessment
- colorretal
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title abstract 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 title abstract 3
- 230000014509 gene expression Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36868702P | 2002-03-29 | 2002-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0303012A true BR0303012A (pt) | 2004-09-08 |
Family
ID=28675528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0303012-1A BR0303012A (pt) | 2002-03-29 | 2003-03-28 | Avaliação de câncer colorretal |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20030186303A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1355151A3 (cg-RX-API-DMAC7.html) |
| JP (2) | JP4354725B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100984996B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN101684500A (cg-RX-API-DMAC7.html) |
| AR (1) | AR039211A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003203561A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0303012A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2422305C (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03002863A (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2475769C (en) * | 2003-08-28 | 2018-12-11 | Veridex, Llc | Colorectal cancer prognostics |
| WO2005066363A2 (en) * | 2004-01-09 | 2005-07-21 | Medigen Biotechnology Corporation | Cancer specific gene ccndbp1 |
| WO2006132788A2 (en) * | 2005-06-06 | 2006-12-14 | Genentech, Inc. | Transgenic models for different genes and their use for gene characterization |
| US8249814B2 (en) * | 2005-10-21 | 2012-08-21 | Genenews Inc. | Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject |
| WO2008045133A2 (en) * | 2006-03-03 | 2008-04-17 | Veridex, Llc | Molecular assay to predict recurrence of dukes' b colon cancer |
| AU2008316313B2 (en) * | 2007-10-23 | 2015-04-16 | Clinical Genomics Pty. Ltd. | A method of diagnosing neoplasms - II |
| EP2169078A1 (en) | 2008-09-26 | 2010-03-31 | Fundacion Gaiker | Methods and kits for the diagnosis and the staging of colorectal cancer |
| WO2013092960A1 (en) | 2011-12-22 | 2013-06-27 | Fundacion Gaiker | Methods and kits for the diagnosis of colorectal cancer |
| CN102586423B (zh) * | 2011-12-27 | 2015-01-07 | 盛司潼 | 一种检测结直肠癌易感基因的方法及试剂盒 |
| CN102586420B (zh) * | 2011-12-27 | 2014-10-22 | 盛司潼 | 一种检测乳腺癌易感基因的方法及试剂盒 |
| CN115678994B (zh) * | 2022-01-27 | 2025-01-21 | 上海爱谱蒂康生物科技有限公司 | 一种生物标志物组合、含其的试剂及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US635152A (en) * | 1899-06-05 | 1899-10-17 | Melancthon S Shotwell | Car-body bolster. |
| US6275814B1 (en) * | 1996-11-27 | 2001-08-14 | Investment Strategies Network | Investment portfolio selection system and method |
| US6003018A (en) * | 1998-03-27 | 1999-12-14 | Michaud Partners Llp | Portfolio optimization by means of resampled efficient frontiers |
| US6350578B1 (en) * | 1999-06-25 | 2002-02-26 | The Regents Of The University Of California | Method of quantitating dsDNA |
| US6175824B1 (en) * | 1999-07-14 | 2001-01-16 | Chi Research, Inc. | Method and apparatus for choosing a stock portfolio, based on patent indicators |
-
2003
- 2003-03-21 US US10/394,382 patent/US20030186303A1/en not_active Abandoned
- 2003-03-28 BR BR0303012-1A patent/BR0303012A/pt not_active IP Right Cessation
- 2003-03-28 CA CA2422305A patent/CA2422305C/en not_active Expired - Fee Related
- 2003-03-28 AU AU2003203561A patent/AU2003203561A1/en not_active Abandoned
- 2003-03-29 CN CN200910175739A patent/CN101684500A/zh active Pending
- 2003-03-29 CN CNA031378714A patent/CN1502989A/zh active Pending
- 2003-03-29 KR KR1020030019815A patent/KR100984996B1/ko not_active Expired - Fee Related
- 2003-03-31 EP EP03252024A patent/EP1355151A3/en not_active Withdrawn
- 2003-03-31 MX MXPA03002863A patent/MXPA03002863A/es active IP Right Grant
- 2003-03-31 JP JP2003094744A patent/JP4354725B2/ja not_active Expired - Fee Related
- 2003-04-01 AR ARP030101132A patent/AR039211A1/es not_active Application Discontinuation
-
2009
- 2009-03-31 JP JP2009086981A patent/JP2009153521A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR100984996B1 (ko) | 2010-10-04 |
| KR20030078801A (ko) | 2003-10-08 |
| JP2003325191A (ja) | 2003-11-18 |
| CN101684500A (zh) | 2010-03-31 |
| MXPA03002863A (es) | 2004-08-11 |
| US20030186303A1 (en) | 2003-10-02 |
| JP4354725B2 (ja) | 2009-10-28 |
| EP1355151A2 (en) | 2003-10-22 |
| CA2422305C (en) | 2013-07-30 |
| AU2003203561A1 (en) | 2003-10-23 |
| CA2422305A1 (en) | 2003-09-29 |
| JP2009153521A (ja) | 2009-07-16 |
| EP1355151A3 (en) | 2004-08-25 |
| AR039211A1 (es) | 2005-02-09 |
| CN1502989A (zh) | 2004-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0403169A (pt) | Prognósticos de câncer colorretal | |
| BRPI0518734A2 (pt) | prognàstico de cÂncer de pulmço | |
| Wang et al. | A framework for analyzing DNA methylation data from Illumina Infinium HumanMethylation450 BeadChip | |
| BRPI0603053A (pt) | previsão de reicidiva de osso de cáncer de mama | |
| BRPI0315666B8 (pt) | dna de a34 e a33 do tipo 3, proteínas, seus anticorpos e métodos de tratamento usando os mesmos | |
| PL393466A1 (pl) | Sposób stymulacji biogenicznego wytwarzania metanu z formacji węglowodoronośnych | |
| BR0303091A (pt) | Avaliação de câncer colorretal | |
| BRPI0607576A2 (pt) | sistema e método para pesquisar uma rede ponto-a-ponto | |
| ATE381552T1 (de) | Derivate von 1-piperazin- und 1- homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms | |
| ATE541053T1 (de) | Verfahren und zusammensetzungen zur behandlung von nichtkleinzelligem lungenkrebs | |
| ATE522627T1 (de) | Verfahren zur herstellung von nukleinsäuresonden | |
| DE60140120D1 (de) | Toxizitätstypisierung unter verwendung von leberstammzellen | |
| Mahon et al. | Discontinuation of imatinib in patients with chronic myeloid leukemia who have maintained complete molecular response: update results of the STIM study | |
| AR044099A1 (es) | Pronostico de cancer de mama | |
| EP1355151A3 (en) | Assessing colorectal cancer | |
| DE10345021A1 (de) | Verfahren zur nichtinvasiven Früherkennung von Dickdarmkrebs und/oder Darmkrebsvorläuferzellen | |
| WO2009086000A3 (en) | Biomarkers for trichogenicity | |
| BRPI0403812A (pt) | Prognósticos de câncer coloretal | |
| DE60009530D1 (de) | Genetische toxizitätsmarker, herstellung und verwendung | |
| BRPI0607016A2 (pt) | marcadores polipeptìdicos para o diagnóstico de cáncer de próstata | |
| ATE507304T1 (de) | Nachweis von chromosomalen anormalitäten in aus follikularer flüssigkeit erhaltenen zellen | |
| ATE426168T1 (de) | Verwendung von asc als marker fur kolorektalkarzinome | |
| Ohnmacht et al. | The pharmacogenomic assessment of molecular epithelial-mesenchymal transition signatures reveals drug susceptibilities in cancer cell lines | |
| WO2004035805A3 (en) | Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance | |
| ATE251223T1 (de) | Immuno-magnetische zelltrennung zur erkennung von krebsmetastasenbildung-assozierten genen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |